Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 1.0
VSEE HEALTH, INC. incurred loan of $271,739.13 with an institutional investor at 18% per annum maturing December 8, 2026.
- Instrument
- loan
- Principal
- $271,739.13
- Counterparty
- an institutional investor
- Rate
- 18% per annum
- Maturity
- December 8, 2026
- Event
- incurrence
Exact text from the filing
On June 8, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “SPA”) with an institutional investor (the “Holder”). Pursuant to the SPA, the Company issued the holder an 8% original issue discount secured promissory note in favor of the Holder, in the aggregate principal amount of $271,739.13 (including the original issue discount of $21,739.13) (the “Promissory Note”). The Promissory Note bears an interest rate of 18% per annum and is due and payable on December 8, 2026.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
VSEE HEALTH, INC. entered into Securities Purchase Agreement with an institutional investor valued at aggregate principal amount of $271,739.13 (effective 2026-06-08).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- an institutional investor
- Value
- aggregate principal amount of $271,739.13
- Effective
- 2026-06-08
Exact text from the filing
On June 8, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “SPA”) with an institutional investor (the “Holder”).
View on SEC.gov